In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other medical technology stocks. The MedTech sector is crucial in healthcare, which ...

As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...

For SCP-relevant amounts of 250 pg ... DeutEx is now integrated into the Bruker proteomics ecosystem to support timsTOF, MRMS and MALDI-TOF systems. Dr. Petr Novák, the Head of Structural ...

The National Institute on Alcohol Abuse and Alcoholism awarded more than $300,000 in exploratory funding to a team of researchers at USF to study the cellular and molecular changes underlying damage ...

Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio 43210, United States Native MS Guided Structural Biology Center, The Ohio State University, Columbus, Ohio 43210, ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

Bruker (BRKR) reported $979.6 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 14.6%. EPS of $0.76 for the same period compares to $0.70 a year ago.

Lehtiö-Lab focuses on understanding cancer genotype - molecular phenotype connections by proteogenomics. We develop new wet lab & bioinformatics methods and apply them to cancer precision medicine ...